{"symbol": "RTRX", "companyName": "Retrophin Inc.", "exchange": "NASDAQ Global Market", "industry": "Drug Manufacturers", "website": "http://www.retrophin.com", "description": "Retrophin Inc is a pharmaceutical company based in the United States. Its drug candidates are targeted at serious rare diseases such as gallstones and bile acid synthesis disorders.", "CEO": "Stephen Aselage", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Drug Manufacturers - Major", "Drug Manufacturers"]}